Reasoning
The TP53 VCEP evaluates PS4 from proband phenotype points: Revised Chompret 0.5 point, Classic LFS 1 point, and HER2-positive breast cancer before age 40 0.5 point, with total-point thresholds of Supporting 1-1.5, Moderate 2-3.5, Strong 4-7.5, and Very Strong at least 8. The case materials contain no proband phenotype, cancer diagnosis, age, Chompret/Classic LFS assessment, or case-control counts for this variant, and the literature packet contains zero PMIDs with no packet.ai_classified_papers entries to verify. The governing PS4-Points-Table.pdf was searched for c.-136del and p.?; no variant-specific entry was found. PS4 therefore cannot be assigned from the available evidence.
VCEP rule
PS4 point-based phenotype assessment
Evidence considered
- ClinGen TP53 VCEP PS4-Points-Table.pdf: Revised Chompret = 0.5 point, Classic LFS = 1 point, HER2-positive breast cancer under 40 years = 0.5 point; PS4 thresholds are Supporting 1-1.5, Moderate 2-3.5, Strong 4-7.5, and Very Strong >=8 points.
- Case summary: no phenotype or patient-level clinical observations are recorded; literature_packet.total_pmids = 0 and high_priority_papers and medium_priority_papers are empty.
- Search of the governing PS4-Points-Table.pdf found no c.-136del or p.? variant-specific row.
Still missing
- No proband-level phenotype, cancer diagnosis, age, Revised Chompret status, or Classic LFS status is available.
- No case-control counts or matched-ancestry control frequency are available for an odds-ratio calculation.
- No variant-specific entry was found after searching PS4-Points-Table.pdf for c.-136del and p.?.
Sources